In the summer of this year, revised KDIGO clinical recommendations on mineral and bone disorders (MBD) in chronic kidney disease (CKD) were revised; they were previously adopted in 2009 (CKD-MBD-2009). The article discusses updates in more details. The changes that appeared in the updates (CKD-MBD-2017) concern several chapters: Chapter 3.2: "Diagnosis of CKD-MBD: Bones", Chapter 4.1. "Treatment of CKD-MBD targeted at lowering high serum phosphate and maintaining serum calcium", Chapter 4.2. "Treatment of abnormal PTH levels in CKD-MBD" (PTH – parathyroid hormone), Chapter 4.3. "Treatment of bone with bisphosphonates, other osteoporosis medications, and growth hormone", Chapter 5. "Evaluation and treatment of kidney transplant bone disease". Thus, the updates are related to the diagnosis of MBDs in CKD, the issues of phosphate-lowering therapy, therapy aimed at reducing PTH levels, and management of MBDs in patients with kidney transplant. Updates allow for the diagnosis and management of MBDs in CKD, taking into account modern views on this problem.

Keywords: mineral and bone disorders, chronic kidney disease